跳至主要内容
临床试验/IRCT201305254105N12
IRCT201305254105N12已完成2 期

The Effect of coenzyme Q10 on serum concentrations of pentraxin 3 and metabolic parameters in non-alcoholic fatty liver disease

Vice chancellor for Research, Tabriz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Patients who agree to participate in the study; Women aged 20-50 years (premenopausal) and in men 20-65 years; Patients newly diagnosed. Exclusion criteria: Alcohol intake; Any cause of chronic liver disease other than NAFLD, such as testing positive for hepatitis B, hepatitis C and autoimmune hepatitis – Immune; Suffering from gastrointestinal disease, diabetes and rheumatoid arthritis; Presence of inherited Hemochromatosis (transferrin saturation greater than 45%) and Wilson's disease; Cholestatic liver disease, advanced liver disease, heart failure, thyroid (abnormal TSH) and renal disease; History of cancer and treatment; Receiving supplements of vitamins (A,C,E), antioxidants, fiber and omega-3 within 3 weeks before baseline and during the study; Drugs such as corticosteroids, amiodarone, tamoxifen, cyclins, perhexiline, methotrexate, aspirin and hydralazine; Presence of pregnancy or lactation or menopause; Taking contraceptive drugs; Liver transplantation; Gastric bypass surgery; Performing a complete intravenous feeding; Rapid weight loss; Cut part of the intestine and gastropathy; Follow the diet and weight loss, Cachexia and Taking anticoagulation.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for Research, Tabriz University of Medical Sciences

相似试验